| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,650 |
5,434 |
$313K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,398 |
2,615 |
$258K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,746 |
2,174 |
$188K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,241 |
2,062 |
$170K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,906 |
1,721 |
$158K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
718 |
644 |
$58K |
| 90686 |
|
4,498 |
3,875 |
$47K |
| 96127 |
|
2,842 |
2,370 |
$43K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,223 |
1,795 |
$36K |
| 90670 |
|
1,707 |
1,416 |
$29K |
| D1206 |
Topical application of fluoride varnish |
1,030 |
736 |
$27K |
| 90677 |
|
250 |
205 |
$23K |
| 90651 |
|
764 |
672 |
$21K |
| 90698 |
|
1,323 |
1,149 |
$15K |
| 95930 |
|
299 |
148 |
$14K |
| 90633 |
|
990 |
739 |
$10K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
825 |
733 |
$10K |
| 90680 |
|
802 |
730 |
$9K |
| 90734 |
|
423 |
387 |
$7K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
173 |
150 |
$7K |
| 0071A |
|
159 |
152 |
$7K |
| 0072A |
|
137 |
137 |
$6K |
| 90744 |
|
497 |
434 |
$5K |
| 90620 |
|
329 |
299 |
$5K |
| 0001A |
|
122 |
122 |
$5K |
| 92558 |
|
433 |
299 |
$5K |
| 90648 |
|
572 |
427 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
171 |
123 |
$5K |
| 90723 |
|
352 |
256 |
$4K |
| 0124A |
|
97 |
82 |
$4K |
| 0002A |
|
97 |
97 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
71 |
70 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
210 |
190 |
$3K |
| 90681 |
|
111 |
94 |
$3K |
| 90619 |
|
125 |
120 |
$2K |
| 0081A |
|
48 |
37 |
$2K |
| 0054A |
|
50 |
48 |
$2K |
| 99383 |
|
21 |
20 |
$2K |
| 90715 |
|
152 |
128 |
$2K |
| 91320 |
|
30 |
30 |
$1K |
| 99173 |
|
106 |
78 |
$789.70 |
| 91319 |
|
18 |
17 |
$784.80 |
| 91318 |
|
17 |
15 |
$741.20 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
19 |
14 |
$730.35 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
28 |
25 |
$718.20 |
| 90696 |
|
87 |
83 |
$550.40 |
| 90685 |
|
65 |
45 |
$434.80 |
| 94760 |
|
150 |
104 |
$391.60 |
| 90710 |
|
57 |
57 |
$358.40 |
| 90716 |
|
37 |
36 |
$236.80 |
| 90707 |
|
25 |
25 |
$160.00 |
| A4556 |
Electrodes, (e.g., apnea monitor), per pair |
80 |
57 |
$83.32 |
| A6411 |
Eye pad, non-sterile, each |
291 |
127 |
$44.16 |
| A4558 |
Conductive gel or paste, for use with electrical device (e.g., tens, nmes), per oz |
80 |
57 |
$34.39 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
287 |
262 |
$0.00 |
| 91307 |
|
34 |
29 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
64 |
62 |
$0.00 |
| 99177 |
|
42 |
41 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
16 |
13 |
$0.00 |